D. Tenero

发表

Pharmacokinetics of Eprosartan in Healthy Subjects, Patients with Hypertension, and Special Populations

M. Bottorff, D. Tenero, Michael B. Bottorff, 1999, Pharmacotherapy.

A population analysis of the DGAT1 inhibitor GSK3008356 and its effect on endogenous and meal‐induced triglyceride turnover in healthy subjects

D. Tenero, Malek Okour, R. Brigandi, 2019, Fundamental & clinical pharmacology.

A Review of Eprosartan Pharmacokinetic and Pharmacodynamic Drug Interaction Studies

D. Kazierad, D. Tenero, R. Blum, 1999, Pharmacotherapy.

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers

D. Kazierad, D. Jorkasky, D. Tenero, 1997, Clinical pharmacology and therapeutics.

A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects.

S. Khindri, D. Tenero, Malek Okour, 2019, Clinical therapeutics.

Population pharmacokinetics of S(−)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate

N. Eddington, M. Fossler, D. Tenero, 2007, The AAPS Journal.

The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency

D. Sica, T. Gehr, N. Shusterman, 1999, European Journal of Clinical Pharmacology.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model

D. Livermore, J. McCauley, S. Bhavnani, 2017, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers

D. Gardiner, D. Tenero, A. Raychaudhuri, 2018, Clinical pharmacology in drug development.

Steady‐State Pharmacokinetics of Carvedilol and Its Enantiomers in Patients with Congestive Heart Failure

D. Jorkasky, S. Brozena, D. Tenero, 2000, Journal of clinical pharmacology.

Intrapulmonary Pharmacokinetics of GSK2251052 in Healthy Volunteers

K. Rodvold, G. Bowers, J. Tomayko, 2013, Antimicrobial Agents and Chemotherapy.

Dose‐Proportional Stereoselective Kinetics of Carvedilol in Patients with CHF

D. Jorkasky, S. Brozena, D. Tenero, 1996 .

Dilevalol: An Overview of Its Clinical Pharmacology and Therapeutic Use in Hypertension

D. Kazierad, R. Lalonde, D. Tenero, 1990, Pharmacotherapy.

Pharmacokinetics and Protein Binding of Eprosartan in Hemodialysis‐Dependent Patients with End‐Stage Renal Disease

D. Jorkasky, D. Tenero, S. J. Kovacs, 1999, Pharmacotherapy.

Effect of Hepatic Disease on the Pharmacokinetics and Plasma Protein Binding of Eprosartan

D. Jorkasky, D. Tenero, D. Martin, 1998, Pharmacotherapy.

Effects of age on the protein binding and disposition of propranolol stereoisomers

M. Bottorff, R. Lalonde, V. Herring, 1990, Clinical pharmacology and therapeutics.

Nonlinear accumulation of propranolol enantiomers.

R. Straka, M. Bottorff, R. Lalonde, 1988, British journal of clinical pharmacology.

Pharmacokinetics and pharmacodynamics of dilevalol

M. Bottorff, M. Affrime, R. Lalonde, 1989, Clinical pharmacology and therapeutics.

Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.

T. Danoff, D. Tenero, D. Boyle, 2006, The American journal of cardiology.

Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.

M. Packer, B. Greenberg, D. Tenero, 2006, The American journal of cardiology.

Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria

N. Goyal, Justin A. Green, D. Tenero, 2015, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with 1 Cefepime in an In Vitro Infection Model 2 3 Running title : PK-PD of Tazobactam

D. Livermore, J. McCauley, S. Bhavnani, 2017 .

Effect of age and gender on the pharmacokinetics of eprosartan.

D. Jorkasky, D. Tenero, N. Zariffa, 1998, British Journal of Clinical Pharmacology.

Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food

D. Jorkasky, D. Lundberg, D. Tenero, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetic properties of a new controlled-release formulation of carvedilol.

T. Danoff, D. Tenero, D. Boyle, 2006, The American journal of cardiology.

Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict beta1-blockade in patients with congestive heart failure.

D. Tenero, D. Boyle, L. S. Henderson, 2006, The American journal of cardiology.

Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic

M. Reese, G. Bowers, J. Tomayko, 2013, Drug Metabolism and Disposition.

Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial

N. Goyal, G. Koh, S. Duparc, 2018, Antimicrobial Agents and Chemotherapy.

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment

M. Davies, D. Tenero, Alfonso Mendoza-Losana, 2019, Antimicrobial Agents and Chemotherapy.

The Challenge of Antimicrobial Resistance: New Regulatory Tools to Support Product Development

J. Rex, B. Eisenstein, B. Eisenstein, 2014, Clinical pharmacology and therapeutics.

Pharmacokinetics and Protein Binding of Eprosartan in Healthy Volunteers and in Patients with Varying Degrees of Renal Impairment

D. Jorkasky, D. Tenero, N. Zariffa, 1998, Journal of clinical pharmacology.

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects

D. Tenero, A. Cobitz, S. Caltabiano, 2018, Pharmacology research & perspectives.

Investigation of the interaction between argatroban and acetaminophen, lidocaine, or digoxin.

R. Dicicco, A. Graham, D. Tenero, 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic

M. Reese, G. Bowers, J. Tomayko, 2013, Drug Metabolism and Disposition.

Ethanol Does Not Alter the Pharmacokinetic Profile of the Controlled‐release Formulation of Carvedilol

T. Danoff, D. Tenero, L. S. Henderson, 2007, Journal of clinical pharmacology.